202 related articles for article (PubMed ID: 10216521)
1. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
[TBL] [Abstract][Full Text] [Related]
2. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
4. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation regulates p27kip1 expression in rodent pituitary cell lines.
Qian X; Jin L; Kulig E; Lloyd RV
Am J Pathol; 1998 Nov; 153(5):1475-82. PubMed ID: 9811339
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
Komatsubara K; Tahara S; Umeoka K; Sanno N; Teramoto A; Osamura RY
Endocr Pathol; 2001; 12(2):181-8. PubMed ID: 11579684
[TBL] [Abstract][Full Text] [Related]
7. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of galectin-3 in pituitary tumors.
Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
[TBL] [Abstract][Full Text] [Related]
10. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
11. P27/CDKN1B Translational Regulators in Pituitary Tumorigenesis.
Martins CS; Camargo RC; Saggioro FP; Neder L; Machado HR; Moreira AC; de Castro M
Horm Metab Res; 2016 Dec; 48(12):840-846. PubMed ID: 27824399
[TBL] [Abstract][Full Text] [Related]
12. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A
Proc Natl Acad Sci U S A; 1999 May; 96(11):6382-7. PubMed ID: 10339596
[TBL] [Abstract][Full Text] [Related]
13. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
14. Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas.
Tanaka C; Yoshimoto K; Yang P; Kimura T; Yamada S; Moritani M; Sano T; Itakura M
J Clin Endocrinol Metab; 1997 Sep; 82(9):3141-7. PubMed ID: 9284759
[TBL] [Abstract][Full Text] [Related]
15. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
16. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
Franklin DS; Godfrey VL; Lee H; Kovalev GI; Schoonhoven R; Chen-Kiang S; Su L; Xiong Y
Genes Dev; 1998 Sep; 12(18):2899-911. PubMed ID: 9744866
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of p21 and p27 genes in human pituitary adenomas.
Ikeda H; Yoshimoto T; Shida N
Br J Cancer; 1997; 76(9):1119-23. PubMed ID: 9365157
[TBL] [Abstract][Full Text] [Related]
18. Expression of P27kip1 and Ki-67 in pituitary adenomas: an investigation of marker of adenoma invasiveness.
Zhao D; Tomono Y; Nose T
Acta Neurochir (Wien); 1999; 141(2):187-92. PubMed ID: 10189502
[TBL] [Abstract][Full Text] [Related]
19. The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumors.
Musat M; Korbonits M; Pyle M; Gueorguiev M; Kola B; Morris DG; Powell M; Dumitrache C; Poiana C; Grossman AB
Pituitary; 2002; 5(4):235-42. PubMed ID: 14558671
[TBL] [Abstract][Full Text] [Related]
20. The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.
Wilson JC; Zhu JJ; Black PM
J Neurooncol; 1999 Aug; 44(1):35-9. PubMed ID: 10582666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
